Walpar Nutritions share news and announcements

NSE: WALPARPharmaceuticals & Biotechnology

₹26.10₹0.00 (0.00%)

Share price at the NSE close on 13 Oct 2026. Previous close ₹26.10.

52-week range of traded prices to 13 Oct 2026

₹21.25Low, 12 Jun 2026₹50.60High, 22 Dec 2025

Market cap: ₹25 Cr
P/E: 9.9
P/B: 1.3
Dividend yield: Nonein the last 12 months
ROE: 14.0%
Debt to equity: 0.76
Volume, NSE: 2,000100.0% delivered

Walpar Nutritions disputes and clarifications

13 filed, newest first.

Jul 2026
- 14 Jul · Legal
  Exchange had sought clarification from Walpar Nutritions Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed. (opens in a new tab)
- 3 Jul · Legal
  Significant movement in price has been observed in Walpar Nutritions Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. (opens in a new tab)
May 2026
- 4 May · Legal
  Exchange had sought clarification from Walpar Nutritions Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed. (opens in a new tab)
Jan 2026
- 8 Jan · Legal
  Exchange has sought clarification from Walpar Nutritions Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted in XBRL with discrepancies The response of the Company is awaited. (opens in a new tab)
Jun 2025
- 21 Jun · Legal
  Exchange has sought clarification from Walpar Nutritions Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted in XBRL with discrepancies The response of the Company is awaited. (opens in a new tab)
Jul 2024
- 2 Jul · Legal
  Exchange had sought clarification from Walpar Nutritions Limited for the quarter ended 31-Mar-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Segment details not submitted The response of the Company is enclosed. (opens in a new tab)
Jun 2024
- 20 Jun · Legal
  Exchange has sought clarification from Walpar Nutritions Limited for the quarter ended 31-Mar-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited. (opens in a new tab)
Jul 2023
- 31 Jul · Legal
  Exchange had sought clarification from Walpar Nutritions Limited for the quarter ended 31-Mar-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Segment details not submitted The response of the Company is enclosed. (opens in a new tab)
Jun 2023
- 16 Jun · Legal
  Exchange has sought clarification from Walpar Nutritions Limited for the quarter ended 31-Mar-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited. (opens in a new tab)
Jun 2022
- 21 Jun · Legal
  Exchange had sought clarification from Walpar Nutritions Limited for the quarter ended 31-Mar-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Segment details not submitted The response of the Company is enclosed. (opens in a new tab)
- 15 Jun · Legal
  Exchange has sought clarification from Walpar Nutritions Limited for the quarter ended 31-Mar-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited. (opens in a new tab)
Feb 2022
- 1 Feb · Legal
  Exchange had sought clarification from Walpar Nutritions Limited with respect to announcement dated 11-Jan-2022, regarding resignation of Mr. Parin Patel as Independent Director of the company w.e.f. January 11, 2022. On basis of above the Company was required to clarify following: 1. Confirmation from the resigning director that there are no other material reasons other than provided; 2. The Letter of resignation of the independent director mentioning the detailed reasons for the resignation; 3. Names of listed entities in which the resigning director holds directorships, indicating the category of directorship and membership of board committees, if any. The response of the Company is attached. (opens in a new tab)
Jan 2022
- 19 Jan · Legal
  Exchange has sought clarification from Walpar Nutritions Limited with respect to announcement dated 11-Jan-2022, regarding resignation of Mr. Parin Patel as Independent Director of the company w.e.f. January 11, 2022. On basis of above the Company is required to clarify following: 1. Confirmation from the resigning director that there are no other material reasons other than provided; 2. The Letter of resignation of the independent director mentioning the detailed reasons for the resignation; 3. Names of listed entities in which the resigning director holds directorships, indicating the category of directorship and membership of board committees, if any. The response of the Company is awaited. (opens in a new tab)

Walpar Nutritions disputes and clarifications

Jul 2026

May 2026

Jan 2026

Jun 2025

Jul 2024

Jun 2024

Jul 2023

Jun 2023

Jun 2022

Feb 2022

Jan 2022